GlassScriptPhysician profile
Shannon C Lynch
NPI 1164472502
$2,326.86
in general payments reported to CMS, 2019-2025
7 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.81 · 2021: $52.97 · 2022: $117 · 2023: $470 · 2024: $617 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,090.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $962.39 | 2024-2025 | Tepezza, Uplizna |
| Horizon Therapeutics Plc | $523.63 | 2019-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $505.11 | 2025 | Stellaris, Xiidra, Miebo |
| Genentech USA, INC. | $147.59 | 2023 | Vabysmo |
| Sight Sciences, INC. | $78.73 | 2024 | Omni Surgical System |
| Argenx US, INC. | $74.55 | 2025 | Vyvgart Hytrulo |
| Dompe US, INC. | $34.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.